As fibronectin has been shown to induce MMP9S ecretion in tumor cells [40] it is possible that some of reduced MMP9S ecretion seen in response to dynamin inhibition is secondary to its effects on fibronectin. The gene discussed is DNM1; the disease is neoplasm.